Product image coming soon
CJC-1295 No DAC + Ipamorelin Blend
10mg
Synergistic GHRH + GHRP blend for amplified, dual-pathway GH release.
- Dosage
- 10mg
- Purity
- ≥ 98% (HPLC tested)
- Form
- Blend
- SKU
- VLT-BLEND-10
- Kit Contents
- 10mg combined sterile lyophilized powder vial (5mg + 5mg)
This product represents the gold standard dual-action synergistic blend in Growth Hormone research. It combines a GHRH analog (CJC-1295 No DAC) and a GHRP agonist (Ipamorelin). When introduced concurrently, they attack the pituitary gland via two separate biological pathways: CJC-1295 amplifies the overall amplitude of the growth hormone pulse, while Ipamorelin amplifies the number of somatotropes releasing GH while suppressing somatostatin. The resulting GH release is exponentially greater than what either peptide could achieve on its own.
